Therapeutic Area | MeSH |
---|---|
nutritional and metabolic diseases | D009750 |
endocrine system diseases | D004700 |
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
type 2 diabetes mellitus | EFO_0001360 | D003924 | E11 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | 5 | 3 | 16 | 29 | 16 | 68 |
Diabetes mellitus | D003920 | EFO_0000400 | E08-E13 | 1 | 3 | 14 | 26 | 16 | 59 |
Overweight | D050177 | — | E66.3 | 2 | 3 | — | 1 | 2 | 7 |
Glucose intolerance | D018149 | HP_0000833 | R73.03 | — | — | — | 5 | 1 | 6 |
Coronary disease | D003327 | — | — | — | — | 2 | 3 | — | 5 |
Obesity | D009765 | EFO_0001073 | E66.9 | — | 1 | — | 3 | 1 | 5 |
Coronary artery disease | D003324 | — | I25.1 | — | — | 1 | 3 | — | 4 |
Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | — | — | 1 | 3 | — | 4 |
Cardiovascular diseases | D002318 | EFO_0000319 | I98 | — | — | 1 | 1 | 1 | 3 |
Atherosclerosis | D050197 | EFO_0003914 | I25.1 | — | — | 1 | 1 | 1 | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Glucose metabolism disorders | D044882 | — | — | — | — | 1 | — | 1 | 2 |
Metabolic diseases | D008659 | EFO_0000589 | E88.9 | — | — | 1 | — | 1 | 2 |
Hypertension | D006973 | EFO_0000537 | I10 | — | — | 1 | — | — | 1 |
Hypercholesterolemia | D006937 | — | — | — | — | 1 | — | — | 1 |
Gestational diabetes | D016640 | — | O24.4 | — | — | 1 | — | — | 1 |
Pregnancy in diabetics | D011254 | — | O24.91 | — | — | 1 | — | — | 1 |
Metabolic syndrome | D024821 | EFO_0000195 | E88.810 | — | — | 1 | — | — | 1 |
Inflammation | D007249 | MP_0001845 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypotension | D007022 | EFO_0005251 | I95 | 1 | 2 | — | — | — | 3 |
Aging | D000375 | GO_0007568 | R41.81 | — | 2 | — | — | — | 2 |
Syncope | D013575 | — | G90.01 | — | 1 | — | — | — | 1 |
Body weight | D001835 | EFO_0004338 | — | 1 | 1 | — | — | — | 1 |
Liver diseases | D008107 | EFO_0001421 | K70-K77 | — | 1 | — | — | — | 1 |
Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 1 | — | — | — | 1 |
Fatty liver | D005234 | EFO_0003934 | — | — | 1 | — | — | — | 1 |
Renal cell carcinoma | D002292 | EFO_0000376 | — | — | 1 | — | — | — | 1 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | 1 | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Pure autonomic failure | D054970 | — | — | 1 | — | — | — | — | 1 |
Orthostatic hypotension | D007024 | — | I95.1 | 1 | — | — | — | — | 1 |
Congenital hyperinsulinism | D044903 | — | — | 1 | — | — | — | — | 1 |
Nesidioblastosis | D046768 | EFO_0007318 | E16.9 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Stroke | D020521 | EFO_0000712 | I63.9 | — | — | — | — | 2 | 2 |
Heart failure | D006333 | EFO_0003144 | I50 | — | — | — | — | 2 | 2 |
Pancreatitis | D010195 | EFO_0000278 | K85 | — | — | — | — | 2 | 2 |
Polycystic ovary syndrome | D011085 | EFO_0000660 | E28.2 | — | — | — | — | 2 | 2 |
Transient ischemic attack | D002546 | EFO_0003764 | G45.9 | — | — | — | — | 1 | 1 |
Pathologic constriction | D003251 | — | — | — | — | — | — | 1 | 1 |
Stents | D015607 | — | — | — | — | — | — | 1 | 1 |
Ischemic stroke | D000083242 | — | — | — | — | — | — | 1 | 1 |
Cognitive dysfunction | D060825 | — | G31.84 | — | — | — | — | 1 | 1 |
Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | — | — | — | — | 1 | 1 |
Drug common name | Acarbose |
INN | acarbose |
Description | (2R,3R,4R,5S,6R)-5-[[(2R,3R,4R,5S,6R)-5-[[(2R,3R,4S,5S,6R)-3,4-dihydroxy-6-methyl-5-[[(1S,4R,5S,6S)-4,5,6-trihydroxy-3-(hydroxymethyl)-1-cyclohex-2-enyl]amino]-2-oxanyl]oxy]-3,4-dihydroxy-6-(hydroxymethyl)-2-oxanyl]oxy]-6-(hydroxymethyl)oxane-2,3,4-triol is a glycoside and an amino cyclitol. |
Classification | Oligosaccharide |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | C[C@H]1O[C@H](O[C@@H]2[C@@H](CO)O[C@H](O[C@@H]3[C@@H](CO)O[C@@H](O)[C@H](O)[C@H]3O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1N[C@H]1C=C(CO)[C@@H](O)[C@H](O)[C@H]1O |
PDB | — |
CAS-ID | 56180-94-0 |
RxCUI | — |
ChEMBL ID | CHEMBL1566 |
ChEBI ID | — |
PubChem CID | 444254 |
DrugBank | DB00284 |
UNII ID | T58MSI464G (ChemIDplus, GSRS) |